Equifax Inc (EFX) is overvalued and we do not publish a verdict for SBC Medical Group Holdings Inc (SBC).
We publish an intrinsic value for EFX but not for SBC, so the two cannot be ranked on price.
Values as of the 19 Oct 2026 close.
Discounting its cash flows at 9.8% (average of 3 methods) values the shares at $130.54; the price of $158.57 is 21% above that value, and 73% of that value comes from beyond year five.
Leak Score 50/100 on 12 of 12 signals
We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.
Leak Score 84/100 on 6 of 12 signals
| Metric | EFX | SBC |
|---|---|---|
| Verdict | Overvalued | Not valued |
| Price | $158.57 | $5.36 |
| Intrinsic value | $130.54 | — |
| Margin of safety | -21% | — |
| Leak Score | 50/100 (12/12) | 84/100 (6/12) |
| Market cap | $18.6B | $551M |
| Revenue growth, 5 years | 8.0% | — |
| Operating margin | 18.5% | 37.3% |
| Net margin | 10.7% | 28.0% |
| Return on equity | 14.6% | 19.3% |
| Debt to equity | 1.25 | 0.18 |
| P/E | 27.9x | 11.2x |
| Forward P/E | 16.0x | 10.3x |
| P/B | 4.3x | 2.1x |
| Dividend yield | 1.4% | — |